Concertobio
Cambridge, US · Founded 2020 · Delaware corporation · 7 known investors
Find your way into Concertobio
1,146 people in our graph share verified history with the Concertobio team — schools, employers, funds. One of them is your warm intro.
Scott Davisunlockedknows Bernardo Cervantes · together at University of California, Berkeley (overlapped)
×3knows the team · via University of California, Berkeley
×3knows the team · via Massachusetts Institute of Technology (MIT)
×4knows the team · via Massachusetts Institute of Technology
knows the team · via University of California San Diego
Concerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition. Its approach combines high-throughput experimental data generation with predictive modeling to make microbial communities engineerable.
Founders & leadership
Concertobio was founded in 2020 by Jared Kehe, Cheri Ackerman, and Bernardo Cervantes.
JK
Jared KeheinCofounder and Chief Scientific OfficerJared Kehe is a co-founder and Executive Officer at Concerto Bio, where he oversees product discovery and technology development. He holds a PhD in Biological Engineering from MIT, where he worked with Prof. Paul Blainey on microfluidics technology applied to microbial ecology, and a BS in Bioengineering from UC San Diego.
CA
Cheri AckermaninCofounder & CEO
BC
Bernardo CervantesinCo-founder · Chief Operating OfficerBernardo Cervantes trained as a microbiologist and microbial engineer with 15 years of experience in molecular biology research focused on microbial engineering for chemical production and human health applications. He is Executive Officer and Director at Concerto Bio, which develops microbe-based consumer health products by generating large-scale ecological datasets on microbial communities.
VS
Board
SL
Investors · 7
Reported raises · per SEC filings
Form D private placements$24.5M disclosed across 1 round · 2022
▶$24.5MraisedJun 2022 · 37 investors · BiotechnologyRule 506(b)
▶$24.5MraisedJun 2022 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sarah LuppinoDirector
- Vera SchroederDirector
- Jared KeheExecutive Officer, Director
- Cheri AckermanExecutive Officer, Director
- Bernardo CervantesExecutive Officer, Director
- Offering amount
- $24.5M
- Amount sold
- $24.5M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Concertobio went on to found or lead other companies.
Competitors · 4
by search overlap
bio15 shared keywordsBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Actio Biosciences, Inc.14 shared keywordsActio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions. It focuses on identifying dysregulated gene activity and designing therapies to restore balance and address the root causes of disease.
Scioto Biosciences12 shared keywordsScioto Biosciences is a life sciences company with corporate offices and research facilities in Fishers, Indiana. This page describes its office locations and employee benefits rather than detailing its products.
Ditto Biosciences12 shared keywordsDitto Bio uses AI to identify protein candidates from parasites and pathogens for treating autoimmune diseases. The company mines natural compounds from viruses, ticks, and worms whose immune-modulating properties have evolved over millions of years.
Companies competing with Concertobio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Concertobio do?
- Concerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition. Its approach combines high-throughput experimental data generation with predictive modeling to make microbial communities engineerable.
- Who founded Concertobio?
- Concertobio was founded by Jared Kehe, Cheri Ackerman, Bernardo Cervantes in 2020.
- Who are Concertobio's investors?
- Concertobio's investors include Excelestar Ventures, Golden Seeds, Horizons Ventures, ISV, M Ventures, MassVentures, Axial VC.
- How much funding has Concertobio raised?
- Concertobio has disclosed $24.5M raised across 1 round.
- Where is Concertobio headquartered?
- Concertobio is headquartered in Cambridge, US.